Allucent Expands Strategic Leadership to Advance Centers of Expertise and Fortify Specialty CRO Position

New strategy leaders across key therapeutic areas deepen specialty focus and strengthen integrated drug development approach CARY, N.C., April 7, 2026 /PRNewswire/ -- Allucent, a global specialty CRO purpose-built for small and mid-sized biopharma, today announced new therapeutic strategy...